Department of Gastroenterology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
Korean J Gastroenterol. 2023 Nov 25;82(5):239-247. doi: 10.4166/kjg.2023.102.
BACKGROUND/AIMS: Non-time-sensitive gastrointestinal endoscopy was deferred because of the risk of exposure to coronavirus disease 2019 (COVID-19), but no population-based studies have quantified the adverse impact on gastrointestinal procedures. This study examined the impact of the COVID-19 pandemic on the performance of esophagogastroduodenoscopy (EGD), colonoscopy, ERCP, and abdominal ultrasonography (US) in South Korea.
This nationwide, population-based study compared the claim data of EGD, colonoscopy, ERCP, and abdominal US in 2020 and 2021 (COVID-19 era) with those in 2019 (before the COVID-19 era).
During the first year (2020) of the COVID-19 pandemic, the annual claim data of EGD and colonoscopy were reduced by 6.3% and 6.9%, respectively, but those of ERCP and abdominal US were increased by 1.0% and 2.9%, compared to those in 2019. During the first surge (March and April 2020) of COVID-19, the monthly claim data of EGD, colonoscopy, ERCP, and abdominal US were reduced by 28.8%, 43.8%, 5.1%, and 21.6%, respectively, in March 2020, and also reduced by 17.2%, 32.8%, 4.4%, and 9.5%, respectively, in April 2020, compared to those in March and April 2019. During March and April 2020, the monthly claims of ERCP, compared with those in 2019, declined less significantly than those of EGD and colonoscopy (both p<0.001).
The claims of EGD and colonoscopy were reduced more significantly than those of ERCP and abdominal US during the COVID-19 pandemic because ERCPs are time-sensitive procedures and abdominal USs are non-aerosolized procedures.
背景/目的：由于担心感染 2019 年冠状病毒病（COVID-19），非时间敏感型胃肠内镜检查被推迟，但尚无基于人群的研究量化其对胃肠程序的不良影响。本研究检查了 COVID-19 大流行对韩国食管胃十二指肠镜检查（EGD）、结肠镜检查、内镜逆行胰胆管造影术（ERCP）和腹部超声（US）的影响。
本项全国性、基于人群的研究比较了 2020 年和 2021 年（COVID-19 时代）与 2019 年（COVID-19 之前）EGD、结肠镜检查、ERCP 和腹部 US 的索赔数据。
在 COVID-19 大流行的第一年（2020 年），与 2019 年相比，EGD 和结肠镜检查的年索赔数据分别减少了 6.3%和 6.9%，而 ERCP 和腹部 US 的索赔数据则分别增加了 1.0%和 2.9%。在 COVID-19 的第一波高峰（2020 年 3 月和 4 月）期间，2020 年 3 月 EGD、结肠镜检查、ERCP 和腹部 US 的月索赔数据分别减少了 28.8%、43.8%、5.1%和 21.6%，而 2020 年 4 月，这四个指标的数据分别减少了 17.2%、32.8%、4.4%和 9.5%，与 2019 年 3 月和 4 月相比。在 2020 年 3 月和 4 月期间，与 2019 年相比，ERCP 的月索赔量下降幅度小于 EGD 和结肠镜检查（均<0.001）。
在 COVID-19 大流行期间，EGD 和结肠镜检查的索赔量下降幅度明显大于 ERCP 和腹部 US，这是因为 ERCP 是时间敏感的程序，而腹部 US 是非气溶胶化的程序。
